about
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.Validation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection.Improving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative 'Pre-Review' Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis.Analysis of the mechanisms of human cytotoxic T lymphocyte response inhibition by NO.A DBS method for quantitation of the new oral trypanocidal drug fexinidazole and its active metabolites.Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.The anti-angiogenic activity of IL-12 is increased in iNOS−/− mice and involves NK cellsA randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
P50
Q33681753-AB32B56A-C4B2-4BFE-A080-1DAE6F9413B7Q34500886-C8B0AC39-D81B-4104-BF3D-A2654AF3B084Q36730131-BDDB0422-3061-40BF-80CD-42DBEFCDC4F8Q38231319-A27CB112-29E6-421E-A6B3-3C495408092EQ44160847-A892F153-1CEF-4672-880F-985FEC83C309Q46268194-2C25873A-9D32-4C8E-96DA-77836F935C4BQ47637613-13446572-9DBC-4771-A004-3E866AF14318Q58827994-812F2423-EBB1-46D8-AE8E-35412A3EF557Q61814710-694720A0-7A1E-4C75-9368-97E66FE5F1B9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Séverine Blesson
@ast
Séverine Blesson
@en
Séverine Blesson
@es
Séverine Blesson
@nl
type
label
Séverine Blesson
@ast
Séverine Blesson
@en
Séverine Blesson
@es
Séverine Blesson
@nl
prefLabel
Séverine Blesson
@ast
Séverine Blesson
@en
Séverine Blesson
@es
Séverine Blesson
@nl
P106
P21
P31
P496
0000-0002-3007-8015